Notice of Closed Meeting, 16360 [2018-07814]

Download as PDF 16360 Federal Register / Vol. 83, No. 73 / Monday, April 16, 2018 / Notices (ABRWH), Centers for Disease Control and Prevention, Department of Health and Human Services, has been renewed for a 2-year period through March 22, 2020. FOR FURTHER INFORMATION CONTACT: Theodore Katz, Designated Federal Officer, NIOSH, CDC, 1600 Clifton Road NE, MS E–20, Atlanta, Georgia 30329– 4027, telephone (513) 533–6800, toll free: 1–800–CDC–INFO, email: dcas@ cdc.gov. The Director, Management Analysis and Services Office, has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities, for both the Centers for Disease Control and Prevention and the Agency for Toxic Substances and Disease Registry. Elaine Baker, Director, Management Analysis and Services Office, Centers for Disease Control and Prevention. [FR Doc. 2018–07770 Filed 4–13–18; 8:45 am] Agenda: To review and evaluate grant applications. FOR FURTHER INFORMATION CONTACT: Mikel Walters, Ph.D., Scientific Review Official, NCIPC, CDC, 4770 Buford Highway NE, Mailstop F–63, Atlanta, Georgia 30341, Telephone: (404) 639– 0913; Email: mwalters@cdc.gov. The Director, Management Analysis and Services Office, has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities, for both the Centers for Disease Control and Prevention and the Agency for Toxic Substances and Disease Registry. Elaine Baker, Director, Management Analysis and Services Office, Centers for Disease Control and Prevention. [FR Doc. 2018–07814 Filed 4–13–18; 8:45 am] BILLING CODE 4163–18–P DEPARTMENT OF HEALTH AND HUMAN SERVICES BILLING CODE 4163–18–P Centers for Disease Control and Prevention DEPARTMENT OF HEALTH AND HUMAN SERVICES Mine Safety and Health Research Advisory Committee (MSHRAC) Centers for Disease Control and Prevention Notice of Closed Meeting srobinson on DSK3G9T082PROD with NOTICES Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended, notice is hereby given of the following meeting. The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended, and the Determination of the Director, Management Analysis and Services Office, CDC, pursuant to Public Law 92–463. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP)—RFA–CE–18–004, Research to Evaluate Medication Management of Opioids and Benzodiazepines to Reduce Older Adult Falls. Dates: June 6, 2018 and June 7, 2018. Time: 9:00 a.m.–5:00 p.m., EDT. Place: DoubleTree by Hilton Hotel Atlanta—Buckhead, 3342 Peachtree Road NE, Atlanta, GA 30326. VerDate Sep<11>2014 19:42 Apr 13, 2018 Jkt 244001 Centers for Disease Control and Prevention (CDC), Department of Health and Human Services (HHS). ACTION: Notice of meeting. AGENCY: In accordance with the Federal Advisory Committee Act, the CDC announces the following meeting for the Mine Safety and Health Research Advisory Committee (MSHRAC). This meeting is open to the public, limited only by the space available. The meeting room accommodates approximately 33 people. If you wish to attend in person or by phone, please contact Marie Chovanec by email at MChovanec@ cdc.gov or by phone at 412–386–5302 at least 5 business days in advance of the meeting. DATES: The meeting will be held on May 22, 2018, 8:30 a.m.–4:00 p.m., EDT and May 23, 2018, 8:00 a.m.–12:00 p.m. EDT. SUMMARY: Department of Health and Human Services; the Director, CDC; and the Director, NIOSH, on priorities in mine safety and health research, including grants and contracts for such research, 30 U.S.C. 812(b)(2), Section 102(b)(2). Matters to be Considered: The meeting will focus on mining safety and health research projects and outcomes, including end-of-shift silica monitor; iLOTO iFund project; miner health program; research & practice to protect miners’ hearing health; stone, sand, & gravel sector research priorities; mining program collaborations; and mining innovations research initiative update. The meeting will also include updates from the National Personal Protective Technology Laboratory and the Respiratory Health Division. Agenda items are subject to change as priorities dictate. The Director, Management Analysis and Services Office, has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities, for both the Centers for Disease Control and Prevention and the Agency for Toxic Substances and Disease Registry. Elaine Baker, Director, Management Analysis and Services Office, Centers for Disease Control and Prevention. [FR Doc. 2018–07761 Filed 4–13–18; 8:45 am] BILLING CODE 4163–19–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention Notice of Closed Meeting; Correction Notice is hereby given of a change in the meetings of the Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP)—GH14– 002, Addressing Emerging Infectious Diseases in Bangladesh; GH16–003, Conducting Public Health Research in Thailand: Technical collaboration with the Ministry of Public Health in the Kingdom of Thailand (MOPH); GH16– 006, Conducting Public Health Research ADDRESSES: Patriots Plaza 1, 395 E Street in Kenya; GH17–005, Conducting Public SW, Room 9000, Washington, DC 20201. Health Research in China; April 10, FOR FURTHER INFORMATION CONTACT: 2018, 9:00 a.m.–2:00 p.m., EDT, which Jeffrey H. Welsh, Designated Federal was published in the Federal Register Officer, MSHRAC, NIOSH, CDC, 626 on March 20, 2018, Volume 83, Number Cochrans Mill Road, Pittsburgh, PA 54, pages 12193–12194, and the Disease, 15236, telephone 412–386–4040, fax Disability, and Injury Prevention and 412–386–6614. Control Special Emphasis Panel (SEP)— GH18–002, Strengthening detection of SUPPLEMENTARY INFORMATION: emerging infectious diseases in India; Purpose: This committee is charged GH18–005, Enhancing Capacity for with providing advice to the Secretary, PO 00000 Frm 00076 Fmt 4703 Sfmt 4703 E:\FR\FM\16APN1.SGM 16APN1

Agencies

[Federal Register Volume 83, Number 73 (Monday, April 16, 2018)]
[Notices]
[Page 16360]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2018-07814]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention


Notice of Closed Meeting

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended, notice is hereby given of the following meeting.
    The meeting will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended, and the Determination of the Director, Management 
Analysis and Services Office, CDC, pursuant to Public Law 92-463. The 
grant applications and the discussions could disclose confidential 
trade secrets or commercial property such as patentable material, and 
personal information concerning individuals associated with the grant 
applications, the disclosure of which would constitute a clearly 
unwarranted invasion of personal privacy.

    Name of Committee: Disease, Disability, and Injury Prevention 
and Control Special Emphasis Panel (SEP)--RFA-CE-18-004, Research to 
Evaluate Medication Management of Opioids and Benzodiazepines to 
Reduce Older Adult Falls.
    Dates: June 6, 2018 and June 7, 2018.
    Time: 9:00 a.m.-5:00 p.m., EDT.
    Place: DoubleTree by Hilton Hotel Atlanta--Buckhead, 3342 
Peachtree Road NE, Atlanta, GA 30326.
    Agenda: To review and evaluate grant applications.

FOR FURTHER INFORMATION CONTACT:  Mikel Walters, Ph.D., Scientific 
Review Official, NCIPC, CDC, 4770 Buford Highway NE, Mailstop F-63, 
Atlanta, Georgia 30341, Telephone: (404) 639-0913; Email: 
[email protected].
    The Director, Management Analysis and Services Office, has been 
delegated the authority to sign Federal Register notices pertaining to 
announcements of meetings and other committee management activities, 
for both the Centers for Disease Control and Prevention and the Agency 
for Toxic Substances and Disease Registry.

Elaine Baker,
Director, Management Analysis and Services Office, Centers for Disease 
Control and Prevention.
[FR Doc. 2018-07814 Filed 4-13-18; 8:45 am]
 BILLING CODE 4163-18-P

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.